China NMPA Drug Inspection - Guangdong Yifang Pharmaceutical Co., Ltd - Ranitidine Hydrochloride Capsules
China NMPA drug inspection for Guangdong Yifang Pharmaceutical Co., Ltd published April 18, 2012. Drug: Ranitidine Hydrochloride Capsules. The State Food and Drug Administration (SFDA) of China issued a National Drug Quality Bulletin on April 18, 2012, detail
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guangdong Yifang Pharmaceutical Co., Ltd published April 18, 2012. Drug: Ranitidine Hydrochloride Capsules. The State Food and Drug Administration (SFDA) of China issued a National Drug Quality Bulletin on April 18, 2012, detail
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox